15.05.2019 11:02:07
|
DGAP-CMS: QIAGEN N.V.: Release of a capital market information
DGAP Post-admission Duties announcement: QIAGEN N.V. / Share Buyback Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting With disclosure dated May 10, 2019, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a fourth tranche of up to USD 50 million under the share repurchase program originally announced on January 31, 2018. The number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such tranche of the share repurchase program on May 10, 2019 amounts to 51,672 shares. Shares were bought back as follows:
The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/ share-buyback). The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program is 51,672 shares. The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V. Venlo, 14 May 2019 Managing Board ### QIAGEN
15.05.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | QIAGEN N.V. |
Hulsterweg 82 | |
5912 PL Venlo | |
Netherlands | |
Internet: | www.qiagen.com |
End of News | DGAP News Service |
|
811563 15.05.2019
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu QIAGEN N.V.mehr Nachrichten
Analysen zu QIAGEN N.V.mehr Analysen
07.02.24 | QIAGEN Hold | Jefferies & Company Inc. |